Who Owns Telix Pharmaceuticals Stock?
NASDAQ: TLXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 1.69%
- Held by insiders
- 0.12%
- Institutional holders
- 91
- Institutions 1.7%
- Insiders 0.1%
- Public and other 98.2%
Who owns Telix Pharmaceuticals stock?
Institutional investors own about 1.7% of Telix Pharmaceuticals's shares, spread across 91 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.12% of TLX.
The largest institutional holders are Armistice Capital, LLC (0.49%), FMR, LLC (0.16%) and BLAIR WILLIAM & CO/IL (0.14%). Together, the top 10 institutions control 1.4% of shares outstanding. In their latest filings, 7 of the top 10 institutions increased their TLX positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of TLX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Armistice Capital, LLC | 1.67M | 0.49% | +100.0% |
| FMR, LLC | 550.55K | 0.16% | -1.9% |
| BLAIR WILLIAM & CO/IL | 480.69K | 0.14% | +290.9% |
| Farallon Capital Management LLC | 419.00K | 0.12% | +100.0% |
| ArrowMark Colorado Holdings LLC | 392.00K | 0.12% | +100.0% |
| Lazard Asset Management LLC | 291.49K | 0.09% | +2.6% |
| Portland Investment Counsel Inc. | 266.20K | 0.08% | 0.0% |
| Hennion & Walsh Asset Management, Inc. | 215.86K | 0.06% | +43.8% |
| Private Advisor Group, LLC | 204.16K | 0.06% | +3.5% |
| Integrated Wealth Concepts LLC | 164.40K | 0.05% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of TLX
| Fund | Shares | % Held |
|---|---|---|
| iShares Trust-iShares Core MSCI EAFE ETF | 2.10M | 0.62% |
| iShares Trust-iShares MSCI EAFE Small-Cap ETF | 996.11K | 0.29% |
| SPDR INDEX SHARES Fd.S-State Street SPDR PORT. Developed World ex-US E | 696.77K | 0.20% |
| iShares Trust-iShares Core MSCI Total International Stock ETF | 407.90K | 0.12% |
| iShares Trust-iShares Core MSCI International Developed Markets ETF | 368.92K | 0.11% |
| iShares Trust-iShares Core MSCI Pacific ETF | 76.84K | 0.02% |
| iShares Trust-iShares International Small-Cap Equity Factor ETF | 51.63K | 0.02% |
| iShares Trust-iShares MSCI World Small-Cap ETF | 16.10K | 0.00% |
| SPDR INDEX SHARES Fd.S-State Street SPDR PORT. MSCI Global Stock Marke | 13.68K | 0.00% |
| Oak Associates Funds-RIVER OAK DISCOVERY FUND | 11.07K | 0.00% |
Frequently asked questions
Who is the largest shareholder of Telix Pharmaceuticals?
Armistice Capital, LLC is the largest institutional shareholder of TLX, owning 0.49% of shares outstanding (1.67M shares) as of its latest 13F filing.
What percentage of Telix Pharmaceuticals is owned by institutions?
Institutions own about 1.7% of TLX shares and 1.7% of the public float.
How much of Telix Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 0.12% of TLX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.